Spotlight Pathology raised €1.6M in a Seed round in Mar 2026. The company is based in Manchester, UK. Investors in the round: UK Innovation and Science Seed Fund (UKI2S). Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
